Stockreport
Bioactive Dressings Market worth $5.8 billion by 2029 driven by Increasing Tech Innovations | MarketsandMarkets™ [Yahoo! Finance]
Last mimedx group, inc earnings: 4/28 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations: phx.corporate-ir.net/phoenix.zhtml?c=213465&p=irol-irhome
reach USD 5.8 billion by 2029 at a CAGR of 10.5% during the forecast period. The global bioactive dressings market is experiencing growth due to rising chronic diseases like diabetes and increased government healthcare spending, though hindered by high product costs and limited reimbursement policies. Bioactive dressings, crucial for healing chronic wounds such as diabetic ulcers and pressure ulcers, are seeing demand driven by advancements in wound care. Opportunities lie in emerging markets like Asia Pacific and Latin America , while regulatory approval challenges slow product introduction. In 2023, the chronic wounds and hospitals & clinics segments led in terms of application and end-users, respectively. North America dominated the market due to high prevalence of chronic wounds and healthcare expenditure. Key players include Smith+Nephew, Organogenesis, MiMedx, 3M , and Cardinal Health. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=35140398 Br
[Read more]
IMPACT SNAPSHOT | EVENT TIME: | MDXG | ||||
---|---|---|---|---|---|---|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
LAST PRICE | ||
VWAP | ||
High:
|
MAX UP |
High:
|
Low:
|
MAX DOWN |
Low:
|
%
|
POST NEWS RANGE |
%
|
|
PRICE CHANGE |
|
|
PRICE CHANGE PERCENTAGE |
|
|
S&P 500 (SPX) |
|
%
|
VOLUME RATIO |
%
|
VOLUME (SHARES) | ||
TICKS | ||
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
MDXG alerts
MDXG alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDXG alerts
High impacting MiMedx Group, Inc news events
Weekly update
A roundup of the hottest topics
MDXG
NEWS
NEWS
- Here's Why We Think MiMedx Group (NASDAQ:MDXG) Might Deserve Your Attention Today [Yahoo! Finance][Yahoo! Finance]
- EX-MiMEDX EMPLOYEES ALLEGE MiMEDX "PRESSURE[D] HEALTHCARE PROVIDERS TO TREAT WOUNDED VETERANS, DIABETICS, CHRONIC WOUND SUFFERERS, AND OTHER PATIENTS WITH MEDICALLY UNNECESSARY OR UNSUITABLE PRODUCTS"[PR Newswire]
- MiMedx Group, Inc. (NASDAQ: MDXG) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.[MarketBeat]
- THIRD DEFENDANT FIGHTS BACK AGAINST MiMEDX, CLAIMING 'DISREPUTABLE AND UNLAWFUL BUSINESS PRACTICES' [Yahoo! Finance][Yahoo! Finance]
- THIRD DEFENDANT FIGHTS BACK AGAINST MiMEDX, CLAIMING 'DISREPUTABLE AND UNLAWFUL BUSINESS PRACTICES'[PR Newswire]
- More
MDXG
SEC Filings
SEC Filings
- 7/31/24 - Form 8-K
- 7/31/24 - Form 10-Q
- 7/10/24 - Form 4
- MDXG's page on the SEC website
- More